Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.6 USD | +5.26% |
|
+2.33% | -11.32% |
15/07 | JPMorgan Trims Price Target on Alkermes to $31 From $32, Maintains Neutral Rating | MT |
01/07 | Alkermes plc(NasdaqGS:ALKS) dropped from Russell 2000 Dynamic Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.32% | 4.16B | |
+25.83% | 47.96B | |
+45.38% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Transcript : Alkermes plc Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 07